Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Infection and Drug Resistance|June 7, 2022
Clinical Implication of the Effect of the Production of Neutralizing Antibodies Against SARS-Cov-2 for Chronic Immune Thrombocytopenia Flare-Up Associated with COVID-19 Infection: A Case Report and the Review of LiteratureChika Maekura, Ayako Muramatsu, Hiroaki Nagata, et al.
International Journal of Molecular Sciences|March 25, 2022
The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple MyelomaReiko Isa, Mano Horinaka, Taku Tsukamoto, et al.
Diagnostics (Basel, Switzerland)|September 28, 2021
Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell LymphomaHaruya Okamoto, Nobuhiko Uoshima, Ayako Muramatsu, et al.
International Journal of Hematology|December 21, 2016
Detection of chromosomal abnormalities by G-banding and prognostic impact in follicular lymphoma in the rituximab eraTaku Tsukamoto, Miki Kiyota, Eri Kawata, et al.
Cancer Science|October 16, 2023
Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B-cell lymphomasYoko Katsuragawa-Taminishi, Shinsuke Mizutani, Yuka Kawaji-Kanayama, et al.
Genes, Chromosomes & Cancer|September 23, 2015
Transcriptional dysregulation of the deleted in colorectal carcinoma gene in multiple myeloma and monoclonal gammopathy of undetermined significanceHisao Nagoshi, Tomohiko Taki, Yoshiaki Chinen, et al.
International Journal of Hematology|October 23, 2020
EWSR1 overexpression is a pro-oncogenic event in multiple myelomaDaichi Nishiyama, Yoshiaki Chinen, Reiko Isa, et al.
International Journal of Clinical Oncology|January 8, 2025
The real-world efficacy and safety of frontline therapy of obinutuzumab plus bendamustine for untreated high-tumor-burden follicular lymphomaHiroaki Nagata, Taku Tsukamoto, Tsutomu Kobayashi, et al.
Cancer Science|December 5, 2023
miR-17-92 cluster-BTG2 axis regulates B-cell receptor signaling in mantle cell lymphomaYuka Kawaji-Kanayama, Taku Tsukamoto, Masakazu Nakano, et al.
Cancer Medicine|May 19, 2020
Serine-227 in the N-terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphomaYayoi Matsumura-Kimoto, Taku Tsukamoto, Yuji Shimura, et al.
Pageof 8